Cliff Asness’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Cliff Asness’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,602	Closed	-$53K	–	2259
2017 Q1	$53K	Buy	+15,602	New	+$73.8K	﹤0.01%	2164
2016 Q2	–	Sell	-4,136	Closed	-$120K	–	2312
2016 Q1	$120K	Sell	4,136 -31,727	-88%	-$861K	﹤0.01%	2174
2015 Q4	$1.33M	Buy	35,863 +2,444	+7%	+$108K	﹤0.01%	1447
2015 Q3	$1.63M	Buy	33,419 +25,462	+320%	+$1.78M	﹤0.01%	1224
2015 Q2	$549K	Buy	+7,957	New	+$368K	﹤0.01%	1734

Other funds holding ANTH

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ECM

Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return

Cliff Asness's ANTH Position: Q2 2017 in Review

Cliff Asness sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 15,602 shares — an estimated $53K sold.

Cliff Asness first reported a position in ANTH in Q2 2015 and held it in 5 quarters. The position peaked at $1.63M in Q3 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

Cliff Asness reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Cliff Asness sold 15,602 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $53K.
Cliff Asness first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
Cliff Asness's Anthera Pharmaceuticals, Inc. position peaked at $1.63M in Q3 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.